CLAIM #43566 · Merck & Company Inc (MRK) · 2025Q2 earnings call · Jul 29, 2025 · due Dec 31, 2025
“As we've been pretty consistently adding 400 to 500 patients per month. So I wouldn't read that the 1,600 in the quarter relative to some shift. It has been actually pretty steady, and we do continue to expect to see that kind of steady growth going forward as we move through the rest of the year.”
Rob Davis · CEO
PENDING
graded after results covering Dec 31, 2025 are reported
Verify independently
SEC filings for MRK ↗ · Claim quote is verbatim from the 2025Q2 earnings call.